The Detection of Parvoviruses

Methods in Molecular Biology

Volumn 665, Issue , 2011, Pages 213-231

  Doyle, Sean ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

B cell ELISpot; Cytokines; ELISA; Erythrovirus; Human bocavirus; Key words; NAT testing; Parvovirus; Recombinant protein

Indexed keywords

DIAGNOSTIC AGENT; PRIMER DNA; SINGLE STRANDED DNA; VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; BOCAVIRUS; CHEMISTRY; COMPARATIVE STUDY; DNA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; DNA PRIMERS; DNA, SINGLE-STRANDED; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROVIRUS; FEMALE; GENOTYPE; HUMAN BOCAVIRUS; HUMANS; PARVOVIRINAE; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 79955865976     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-817-1_13     Document Type: Chapter

References (65)

1. Parsyan, A. and Candotti, D. (2007) Human erythrovirus B19 and blood transfusion – an update. Transfus Med 17, 263–278.
2. Corcoran, A. and Doyle, S. (2004) Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53, 459–475.
3. Nguyen, Q.T., Sifer, C., Schneider, V., Allaume, X., Servant, A., Bernaudin, F., Auguste, V., and Garbarg-Chenon, A. (1999) Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37(8), 2483–2487.
4. Ekman, A., Hokynar, K., Kakkola, L., Kantola, K., Hedman, L., Bondén, H., Gessner, M., Aberham, C., Norja, P., Miettinen, S., Hedman, K., and Söderlund-Venermo, M. (2007) Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol 81, 6927–6935.
5. Broliden, K., Tolfvenstam, T., and Norbeck, O. (2006) Clinical aspects of parvovirus B19 infection. J Intern Med 260(4), 285–304.
6. Falk, R.J., Jennette, J.C., and Kopp, J.B. (2000) Parvovirus B19 DNA in kidney tissue of patients with focal segmental glom-erulosclerosis. Am J Kidney Dis 35(6), 1166–1174.
7. Waldman, M. and Kopp, J.B. (2007) Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2 Suppl 1, S47–S56.
8. Pankuweit, S., Ruppert, V., Eckhardt, H., Strache, D., and Maisch, B. (2005) Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19. J Vet Med B Infect Dis Vet Public Health 52(7–8), 344–347.
9. Streitz, M., Noutsias, M., Volkmer, R., Rohde, M., Brestrich, G., Block, A., Klippert, K., Kotsch, K., Ay, B., Hummel, M., Kühl, U., Lassner, D., Schultheiss, H.P., Volk, H.D., and Kern, F. (2008) NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One 3(6), e2361.
10. Jordan, J., Tiangco, B., Kiss, J., and Koch, W. (1998) Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 75(2), 97–102.
11. Anderson, M.J., Higgins, P.G., Daies, L.R., Willman, J.S., Jones, S.E., Kidd, I.M., Pattison, J.R., and Tyrell, D.A.J. (1985) Experimental parvovirus infection in humans. J Infect Dis 153, 257–265.
12. Brown, C.S., Salimans, M.M., Noteborn, M.H., and Weiland, H.T. (1990) Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res 15(3), 197–211.
13. Kerr, S., O’Keeffe, G., Kilty, C., and Doyle, S. (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57, 179–185.
14. Jordan, J.A. (2001) Diagnosing human parvovirus B19 infection: guidelines for test selection. Mol Diagn 6(4), 307–312.
15. Baschat, A.A., Towbin, J., Bowles, N.E., Harman, C.R., and Weiner, C.P. (2003) Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med 13(6), 381–384.
16. Schmidt, M., Themann, A., Drexler, C., Bayer, M., Lanzer, G., Menichetti, E., Lechner, S., Wessin, D., Prokoph, B., Allain, J.P., Seifried, E., and Hourfar, M.K. (2007) Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 47, 1775–1782.
17. Corcoran, A., Kerr, S., Koppelman, M., and Doyle, S. (2007) Improved detection of acute parvovirus B19 infection by IgM EIA in combination with a novel antigen EIA. Vox Sang 93, 216–222.
18. Sakata, H., Ihara, H., Sato, S., Kato, T., Ikeda, H., and Sekiguchi, S. (1999) Efficiency of donor screening for human parvovirus B19 by the receptor-mediated hemagglutination assay method. Vox Sang 77, 197–203.
19. Wakamatsu, C., Takakura, F., Kojima, E., Kiriyama, Y., Goto, N., Matsumoto, K., Oyama, M., Sato, H., Okochi, K., and Maeda, Y. (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76, 14–21.
20. Lowin, T., Raab, U., Schroeder, J., Franssila, R., and Modrow, S. (2005) Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors. J Vet Med B Infect Dis Vet Public Health 52, 348–352.
21. Nam, J.M., Jang, K.J., and Groves, J.T. (2007) Detection of proteins using a colorimetric bio-barcode assay. Nat Protoc 2(6), 1438–1444.
22. Ferguson, M. and Heath, A. (2004) Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody. Biologicals 32(4), 207–212.
23. Saldanha, J., Lelie, N., Yu, M.W., and Heath, A.; B19 Collaborative Study Group. (2002) Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 82(1), 24–31.
24. Allander, T., Tammi, M.T., Eriksson, M., Bjerkner, A., Tiveljung-Lindell, A., and Andersson, B. (2005) Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102(36), 12891–12896.
25. Allander, T. (2008) Human bocavirus. J Clin Virol 41(1), 29–33.
26. Schildgen, O., Müller, A., Allander, T., Mackay, I.M., Völz, S., Kupfer, B., and Simon, A. (2008) Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev 21(2), 291–304.
27. Choi, J.H., Chung, Y.S., Kim, K.S., Lee, W.J., Chung, I.Y., Oh, H.B., and Kang, C. (2008) Development of real-time PCR assays for detection and quantification of human bocavirus. J Clin Virol 42(3), 249–253.
28. Kantola, K., Hedman, L., Allander, T., Jartti, T., Lehtinen, P., Ruuskanen, O., Hedman, K., and Söderlund-Venermo, M. (2008) Serodiagnosis of human bocavirus infection. Clin Infect Dis 46(4), 540–546.
29. Kahn, J.S., Kesebir, D., Cotmore, S.F., D’Abramo, A. Jr., Cosby, C., Weibel, C., and Tattersall P. (2008) Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 198(1), 41–50.
30. Lin, F., Guan, W., Cheng, F., Yang, N., Pintel, D., and Qiu, J. (2008) ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV. J Virol Methods 149(1), 110–117.
31. Fryer, J.F., Kapoor, A., Minor, P.D., Delwart, E., and Baylis, S.A. (2006) Novel parvovirus and related variant in human plasma. Emerg Infect Dis 12(1), 151–154.
32. Fryer, J.F., Delwart, E., Hecht, F.M., Bernardin, F., Jones, M.S., Shah, N., and Baylis, S.A. (2007) Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47(6), 1054–1061.
33. Schneider, B., Fryer, J.F., Reber, U., Fischer, H.P., Tolba, R.H., Baylis, S.A., and Eis-Hübinger, A.M. (2008) Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 80(2), 345–351.
34. Doyle, S., Kerr, S., O’Keeffe, G., O’Carroll, D., Daly, P., and Kilty, C. (2000) Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 90, 143–152.
35. Corcoran, A., Doyle, S., Waldron, D., Nicholson, A., and Mahon, B.P. (2000) Impaired interferon-g responses against parvovirus B19 by recently infected children. J Virol 74, 9903–9910.
36. Candotti, D., Etiz, N., Parsyan, A., and Allain, J.P. (2004) Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 78(22), 12169–12178.
37. Heegaard, E.D., Qvortrup, K., and Christensen, J. (2002) Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J Med Virol 66(2), 246–252.
38. Corcoran, A., Doyle, S., Allain, J.P., Candotti, D., and Parsyan, A. (2005) Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol 79(8), 5238–5239.
39. Parsyan, A., Kerr, S., Owusu-Ofori, S., Elliott, G., and Allain, J.P. (2006) Reactivity of geno-type-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 44(4), 1367–1375.
40. Kaikkonen, L., Lankinen, H., Harjunpaa, I., Hokynar, K., Soderlund-Venermo, M., Oker-Blom, C., Hedman, L., and Hedman, K. (1999) Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol 37, 3952–3956.
41. Söderlund, M., Brown, C.S., Spaan, W.J., Hedman L., and Hedman, K. (1995) Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172, 1431–1436.
42. Manaresi, E., Gallinella, G., Zerbini, M., Venturoli, S., Gentilomi, G., and Musiani, M. (1999) IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. J Med Virol 57, 174–178.
43. Enders, M., Weidner, A., Rosenthal, T., Baisch, C., Hedman, L., Söderlund-Venermo, M., and Hedman, K. (2008) Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 197(1), 58–62.
44. Corcoran, A., Mahon, B.P., and Doyle, S. (2004) B cell memory is directed towards conformational epitopes of parvovirus B19 capsid proteins and the VP1-unique region. J Infect Dis 189(10), 1873–1880.
45. Corcoran, A., Crowley, B., Dewhurst, C., Pizer, BL., and Doyle, S. (2006) Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection. J Med Virol 78(1), 125–128.
46. Nanan, R., Heinrich, D., Frosch, M., and Kreth, H.W. (2001) Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 20, 498–504.
47. Franssila, R. and Hedman, K. (2004) T-helper cell-mediated interferon-gamma, interleu-kin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Vaccine 22(27–28), 3809–3815.
48. Klenerman, P., Tolfvenstam, T., Price, D.A., Nixon, D.F., Broliden, K., and Oxenius, A. (2002) T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol Biol (Paris) 50(5), 317–325.
49. Isa, A., Lundqvist, A., Lindblom, A., Tolfvenstam, T., and Broliden, K. (2007) Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 147(3), 419–425.
50. Corcoran, A., Mahon, B.P., McParland, P., Davoren, A., and Doyle, S. (2003) Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol 70, 475–480.
51. Aberham, C., Pendl, C., Gross, P., Zerlauth, G., and Gessner, M. (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92(2), 183–191.
52. Baylis, S.A., Fryer, J.F., and Grabarczyk, P. (2007) Effects of probe binding mutations in an assay designed to detect parvovirus B19: implications for the quantitation of different virus genotypes. J Virol Methods 139(1), 97–99.
53. Durigon, E.L., Erdman, D.D., Gary, G.W., Pallansch, M.A., Torok, T.J., and Anderson, L.J. (1993) Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 44(2–3), 155–165.
54. Daly, P., Corcoran, A., Mahon, B.P., and Doyle, S. (2002) High sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 40(6), 1958–1962.
55. Caillet-Fauquet, P., Di Giambattista, M., Draps, M.L., Hougardy, V., de Launoit, Y., and Laub, R. (2004) An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines. Transfusion 44(9), 1340–1343.
56. Modrof, J., Berting, A., Tille, B., Klotz, A., Forstner, C., Rieger, S., Aberham, C., Gessner, M., and Kreil, T.R. (2008) Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion 48(1), 178–186.
57. Wong, S. and Brown, K.E. (2006) Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35(4), 407–413.
58. O’Malley, A., Barry-Kinsella, C., Hughes, C., Kelehan, P., Devaney, D., Mooney, E., and Gillan, J. (2003) Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol 6(5), 414–420.
59. Setúbal, S., de Oliveira, S.A., Pires, A.R., da Fonseca, E.C., Camacho, L.A., Seródio A.C., and do Nascimento, J.P. (2006) Erythrovirus B19 infection in acquired immunodeficiency syndrome: screening by histopathology, immunohistochemistry, and in situ hybridization. Mem Inst Oswaldo Cruz 101(4), 407–414.
60. Landolsi, H., Yacoubi, M.T., Bouslama, L., Lahmar, A., Trabelsi, A., Hmissa, S., Aouni, M., and Korbi, S. (2009) Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and par- affin-embedded placenta and fetal tissues. Pathol Biol (Paris) 57(3), e1–e7.
61. Mehraein, Y., Lennerz, C., Ehlhardt, S., Venzke, T., Ojak, A., Remberger, K., and Zang, K.D. (2003) Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol 16(8), 811–817.
62. Tolfvenstam, T., Papadogiannakis, N., Norbeck, O., Petersson, K., and Broliden, K. (2001) Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357(9267), 1494–1497.
63. Quemelo, P.R., Lima, D.M., da Fonseca, B.A., and Peres, L.C. (2007) Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues. Rev Inst Med Trop Sao Paulo 49(2), 103–107.
64. Lennerz, C., Madry, H., Ehlhardt, S., Venzke, T., Zang, K.D., and Mehraein, Y. (2004) Parvovirus B19-related chronic monoarthri-tis: immunohistochemical detection of virus-positive lymphocytes within the synovial tissue compartment: two reported cases. Clin Rheumatol 23(1), 59–62.
65. Schneider, B., Fryer, J.F., Oldenburg, J., Brackmann, H.H., Baylis, S.A., and Eis-Hübinger, A.M. (2008) Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 14(5), 978–986.